Key result
Targeting TLR4 with TAK-242 ameliorated heart failure and attenuated myocardial injury in aged mice by inhibiting the formation of neutrophil extracellular traps.
Why the study?
The precise role and underlying mechanisms of TLR4 in HF remain poorly understood.
Does TLR4 inhibition improve cardiac function and reduce inflammation in aged mice with isoproterenol-induced heart failure?
Population
18-month-old male C57BL/6J mice with isoproterenol-induced HF
Comparison
TAK-242 vs DNase I vs GSK484
Design
Animal experimental study
Follow-up
7 consecutive days
Authors
Loading...
TLR4 targeting in HF remains hypothesis-generating; does not support clinical use and requires human trials.
Does TLR4 inhibition improve cardiac function and reduce inflammation in aged mice with isoproterenol-induced heart failure?
p-value: p=<0.001
Targeting TLR4 ameliorates heart failure and reduces myocardial inflammation in aged mice by inhibiting the formation of neutrophil extracellular traps.
Liu et al. (2026) studied Heart Failure. TLR4 inhibitor TAK-242 vs. Vehicle was evaluated on Cardiac function and NETs formation (p=<0.001). Targeting TLR4 with TAK-242 ameliorated heart failure and attenuated myocardial injury in aged mice by inhibiting the formation of neutrophil extracellular traps.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: